in vitro News and Research

RSS

U.K. Human Fertilisation and Embryology Authority approves compensation for eggs donated for research

The United Kingdom's Human Fertilisation and Embryology Authority on Wednesday approved a policy that will allow women who donate eggs for human embryonic stem cell research to receive up to $500 for each cycle to cover costs associated with travel and lost wages, the AP/Washington Post reports

25 Feb 2007

microRNA directly regulates a gene implicated in human cancers

MicroRNAs are tiny snippets of RNA that can repress activity of a gene by targeting the gene's messenger RNA (which copies DNA information and starts the process of protein production).

22 Feb 2007

Increased demand, compensation for egg donors in U.S.

The AP/Boston Globe on Monday examined how increased demand for egg donations and compensation for donors in the U.S. has prompted more young women to donate their eggs. According CDC data, about 10,000 women donated eggs to federally monitored programs in 2004, compared with 3,800 women in 1996.

22 Feb 2007

Women who donate eggs for stem cell research face few health risks

Women who donate their eggs for stem cell research or in vitro fertilization are not at increased risk of health complications, and most of the risks are a result of the hormones used to stimulate their bodies to release more than one egg, according to a report commissioned by the California Institute of Regenerative Medicine and released by the Institute of Medicine, Bloomberg reports.

13 Feb 2007

ViroPharma receives orphan drug designation for Maribavir

ViroPharma Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for maribavir for prevention of cytomegalovirus (CMV) viremia and disease in the populations at-risk.

7 Feb 2007

New test shows which breast cancers will recur

Approval has been granted by the FDA for a gene-based test that helps tell early-stage breast cancer patients whether they need chemotherapy after their surgery.

7 Feb 2007

FDA clears MammaPrint test for marketing

The Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.

6 Feb 2007

World's largest particle physics accelerator tackles malaria

Malaria kills more than one million people each year, most of them young children living in Africa. Now physicists in the UK have shared their computers with biologists from countries including France and Korea in an effort to combat the disease.

31 Jan 2007

Small molecule targets weak mRNA

A new strategy for fighting cancer aims to make its genes get lost in translation, according to a report in the January 26, 2007, issue of the journal Cell.

28 Jan 2007

Manipulation of proliferation and differentiation of human bone marrow derived neural stem cells in vitro and in vivo

Stem cells taken from adult human bone marrow have been manipulated by scientists at the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center to generate aggregates of cells called spheres that are similar to those derived from neural stem cells of the brain.

28 Jan 2007

Sequella receives FDA fast track status for pulmonary tuberculosis drug

Sequella, Inc. has announced it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SQ109, the company's proprietary lead drug candidate for treatment of pulmonary tuberculosis (TB).

22 Jan 2007

Nanoparticles from crab shells show promise for drug delivery

Nanoparticles made of chitosan, a naturally occuring polymer isolated from crab and shrimp shells, have shown promise as carriers of anticancer drugs, antitumor genes, and other novel therapeutic agents.

22 Jan 2007

Most fertility clinic web sites do not conform to advertising guidelines

The majority of fertility clinic Web sites do not adhere to their own association's advertising guidelines, according to a University of Illinois at Chicago study published in the January issue of Fertility and Sterility.

18 Jan 2007

In Vitro diagnostic market in Europe

The latest estimates on the In Vitro Diagnostic (IVD) market in Europe, corresponding to the year 2005, are now available.

14 Jan 2007

BIO urges Congress to pass Stem Cell Research Enhancement Act

Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), has issued the following statement on H.R. 3, the Stem Cell Research Enhancement Act of 2007.

9 Jan 2007

Young single men are more likely to bank sperm before testicular cancer treatment

A quarter of men with testicular cancer banked their sperm before treatment, but only six per cent of those actually used the sperm to father a child, according to a study published in the January issue of the UK-based urology journal BJU International.

8 Jan 2007

Dendrimer-encapsulated camptothecins

With an eye toward developing a delivery vehicle for anticancer agents that are poorly soluble in water, a research team at Boston University and the Research Triangle Institute (RTI) has developed a biocompatible dendrimer that wraps itself around water-insoluble drugs.

8 Jan 2007